Past Announcements

November 2019

  • American Cancer Society Announces New Video Series Created to Deliver Clinical and Emotional Support to Cancer Caregivers.  Click here for more.

 

October 2019

  • Could Biosimilars Be Integrated into Alternative Payment Models?  Find out more
  • Nearly 60% of Blood Cancer Patients Covered by Medicare Delay or Forgo Treatment, Find out more
  • Report: Progress in Global Cancer Fight is Not Only Possible, but Achievable, Find out more
  • Walmart to Measure Doctor Quality in Local Markets, Find out more
  • Denial Rates and Days to Pay for Cancer Drugs: Commercial Health Plan Report Card, Click here for more.

September 2019

  • CMS to Collect 340B Drug Cost Information, Click here for more
  • Cancer Drugs Account for 27% of All New Drug Approvals in the US, Click here for more
  • Sharing Hospital Outpatient Payment Proposal Maintains 340B Cuts, Addresses Price Transparency and Prior Authorization, Click here for more.
  • CMS Proposes New Electronic Prior Authorization Process to Speed Access to Care, Find out more
  • Economic Cost of Cancer in U.S. Tops $94B Annually According to a Study, Click here for more.

 July 2019

  • Community Needs More Time to Assess and Comment on CMMI’s Proposed Oncology Care First Model, Find out more
  • Patients Need Protection From Surprise Medical Bills, Organizations Tell Congress, Find out more
  • Cancer Pain Predicted by Lower Anxiety and Depression, Higher Social Support, Find out more
  • United Health and Optum 'Uniting Care and Coverage' in New Model, Find out more
  • New Survey Seeks Provider Input on Clinical Trial Enrollment, Click here for the survey
  • Educate and Support Your Patients with ASCO Answers Materials, Order printed copies online at the ASCO Store.
  • New Technology Add-on Payment: Impact on CAR T-cell Therapy Reimbursement, Click here for more.
  • CMS Expands CAR T-cell Therapy Coverage for Medicare Beneficiaries, Read more here
  • AMA House of Delegates Adopts ASCO Resolutions on Step Therapy, Medicare Part B, Read more on ASCO in Action.
  • Two Cancer Research Organizations Submit Recommendations to FDA Aimed at Reducing Barriers to Clinical Trial Participation, Click here for more.

When a patient’s health insurance plan denies your request for prior authorization (PA) or coverage for a medication, you may submit an appeal. When submitting an appeal to a patient’s health insurance plan, including an Appeal Letter can help explain the rationale and clinical decision-making behind the choice of a specific therapy.

This guide will assist you in composing an Appeal Letter for your patients who have been prescribed a Genentech medicine. You can also access this guide, as well as any enclosures necessary for completing an Appeal Letter, in the Forms and Documents section of Genentech-Access.com.

Read More

Apply for ASCO’s Health Policy Leadership Development Program

Applications are now open for the 2019-2020 ASCO Health Policy Leadership Development Program (HP-LDP). Formerly the Health Policy Fellowship Program, the HP-LDP is a one-year program that provides an opportunity for ASCO members to develop expertise in health policy, advocacy, and grassroots activity.

The HP-LDP is open to all ASCO members in the United States who completed their final subspecialty training between 2009 and 2014.

Click here for more information.